Noninvasive physiologic assessment of coronary stenoses using cardiac CT by Xu, L. et al.
Review Article
Noninvasive Physiologic Assessment of Coronary
Stenoses Using Cardiac CT
Lei Xu,1 Zhonghua Sun,2 and Zhanming Fan1
1 Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
2Discipline of Medical Imaging, Department of Imaging and Applied Physics, Curtin University, Perth, WA 6845, Australia
Correspondence should be addressed to Zhanming Fan; fanzm120@126.com
Received 21 June 2014; Revised 29 September 2014; Accepted 6 October 2014
Academic Editor: Michael Ralph Rees
Copyright © 2015 Lei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Coronary CT angiography (CCTA) has become an important noninvasive imaging modality in the diagnosis of coronary artery
disease (CAD). CCTA enables accurate evaluation of coronary artery stenosis. However, CCTA provides limited information on
the physiological significance of stenotic lesions. A noninvasive “one-stop-shop” diagnostic test that can provide both anatomical
significance and functional significance of stenotic lesions would be beneficial in the diagnosis and management of CAD. Recently,
with the introduction of novel techniques, such as myocardial CT perfusion, CT-derived fractional flow reserve (FFRCT), and
transluminal attenuation gradient (TAG), CCTA has emerged as a noninvasive method for the assessment of both anatomy of
coronary lesions and its physiological consequences during a single study. This review provides an overview of the current status
of new CT techniques for the physiologic assessments of CAD.
1. Introduction
Coronary CT angiography (CCTA) has been widely used as
an effective noninvasive imaging modality in the diagnosis
of coronary artery disease (CAD) [1]. Multiple-center studies
have shown that CCTA allows reliable detection of coronary
artery stenoses with high sensitivity and specificity as com-
pared to conventional coronary angiography [2, 3]. Due to the
remarkably high negative predictive value and noninvasive
nature, the main strength of CCTA is its excellent ability to
exclude significant CAD in selected patients with intermedi-
ate pretest probability [1, 4, 5]. Therefore, CCTA is now well
established as an effective “gatekeeper” to invasive coronary
angiography and may reduce the rate of normal coronary
angiography and improve cost efficiency [6]. Noninvasive
assessment of coronary plaque is important for coronary risk
stratification. In addition to accurate evaluation of luminal
narrowing, CCTA is now a promising approach for noninva-
sive detection of coronary plaque characteristics, including
plaque composition and morphology, and it may therefore
contribute to coronary risk stratification [7–9]. A previous
study has shown that CCTA-based plaque characterization
provides valuable information for the prediction of major
cardiovascular events [10]. CCTAnot only demonstrates high
diagnostic accuracy, but also shows high prognostic value in
CAD with very low rate of adverse cardiac events occurring
in patients with normal CCTA finding and significantly high
rate of these events in patients with obstructive CAD [11–
13]. CCTA is now a mature diagnostic imaging modality
that can provide an effective means to safely guide clinical
decision making [14]. One of the limitations of CCTA is
that the presence of extensively calcified plaque may cause
overestimation of the degree of coronary stenosis, thus
resulting in low positive predictive value and potentially
leading to increased downstream testing [15–17].
Detection of the physiological severity of intermediate
coronary lesions has significant implications for the diagno-
sis, prognosis, and optimal treatment [18, 19]. It has been
shown that only patients with a hemodynamically significant
coronary stenosis benefit from revascularization regardless
of the severity of underlying stenosis [20, 21]. However,
in its current form, CCTA is limited in the physiological
assessment of coronary atherosclerosis and, therefore, it
cannot efficiently discriminate hemodynamically from non-
hemodynamically significant stenosis [1]. Studies have shown
that a 50% stenosis identified by CCTA is a poor predictor
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of ischemia [22–24]. Hence, on identification of the signif-
icance of CCTA findings, patients often require additional
functional tests, as the physiological significance of many
lesions remains uncertain. Given these considerations, a non-
invasive “one-stop-shop” diagnostic test that can provide both
anatomical and hemodynamic significance of stenotic lesions
would be beneficial in the diagnosis of CAD. Recently, with
the introduction of novel techniques, such as myocardial CT
perfusion, noninvasive FFRCT, and transluminal attenuation
gradient, CCTA has emerged as a noninvasive method for
the assessment of both anatomy of coronary lesions and
its physiological consequences during a single study. This
review provides an overview of the current status of new CT
techniques for the physiologic assessments of CAD.
2. Myocardial CT Perfusion Imaging
Nuclear medicine for a long time has played an important
role in the noninvasive evaluation of known or suspected
coronary artery disease. Over the past decades, myocar-
dial perfusion imaging (MPI) using single photon emis-
sion computed tomography (SPECT) or positron emission
tomography (PET) has been well established as the reference
standard for the diagnosis and decision making in patients
with known coronary artery disease [25, 26]. Ameta-analysis
demonstrated that the pooled sensitivity and specificity of
SPECT-MPI was 77% and 77% on a patient level for the
evaluation of functional ischemia with fractional flow reserve
as the reference standard [27]. However, SPECT is still
limited by low spatial resolution and may miss small or
subendocardial areas of hypoperfusion. Attenuation artifact
has long been recognized as a major factor limiting the
specificity of SPECT for the detection of myocardial perfu-
sion defects [28]. Furthermore, SPECT-MPI may miss some
patients with balanced three-vessel disease, as the technique
relies on identifying relative differences in perfusion between
adjacent myocardial territories [29]. Compared with SPECT-
MPI, PET-MPI provides higher spatial resolution, accurate
attenuation correction, and lower radiation doses for the
detection of coronary artery disease [30, 31]. PET perfusion
imaging has an overall sensitivity of 92% and a specificity
of 85% for the detection of coronary artery disease [32].
However, because of cost and logistics, this approach is not
widely available and is not accepted as a clinical routine.
The use of hybrid imaging techniques, such as SPECT-
CT or PET-CT has the advantages of both functional and
anatomic imaging. However, these modalities still require
two separate imaging procedures, resulting in additional cost
and radiation exposure [22, 30]. The advantage of cardiac
magnetic resonance imaging (CMR) over myocardial SPECT
is high spatial resolution and not using ionizing radiation
[33]. A meta-analysis of CMR perfusion study revealed a
sensitivity of 91% and specificity of 81% for the diagnosis of
CAD on a per-patient level [34]. However, CMR examination
is time-consuming as it has long procedure times and limited
accuracy in quantification.MR coronary angiography has not
been widely accepted as a practical diagnostic tool for CAD.
Technical advances with improved spatial and temporal
resolution and subsequently reduced scan time and radiation
exposure have allowed cardiac CT to simultaneously assess
both coronary anatomy and myocardial perfusion.
3. First-Pass Myocardial CT Perfusion
Myocardial CT perfusion imaging (CTP) can be performed
in two ways: first-pass static perfusion imaging and dynamic
CTP. First-pass CCTA imaging has the potential to assess the
physiologic significance of coronary artery lesions [35]. In
this strategy, restmyocardial CTP is obtained from the images
usually acquired during a CCTA examination performed in
rest condition. And stress CTP is acquired by an additional
CCTA study performed under myocardial stress [36, 37].
By using resting CCTA images, coronary artery stenosis
and myocardial perfusion may be evaluated simultaneously
using the same raw data without the need for further scans,
or additional radiation and contrast. However, the value
of rest myocardial CTP for the evaluation of myocardial
ischemia is uncertain. There have been some reports inves-
tigating the detection of myocardial ischemia at rest using
multidetector CT (MDCT). Iwasaki and Matsumoto [36]
studied the incidence of myocardial perfusion defect by 64-
MDCT at rest in patients with significant stenosis and the
effect of coronary revascularization therapy on myocardial
perfusion. The results demonstrated that a significant per-
centage of patients with significant coronary stenosis showed
myocardial perfusion defect by 64-MDCT at rest, and most
of these perfusion defects improved after revascularization
therapy. The results indicate that CCTA has the potential
for the detection of myocardial ischemia at rest. A study by
Busch et al. [38] showed that, in comparison to combined
SPECT and CCTA, myocardial CTP using resting CCTA
images identifies myocardial infarction with high sensitivity
(90%), good specificity (80%), and high negative predictive
value (NPV) (94%). The presence of hypoperfusion on
CTP suggests either myocardial infarction or ischemia with
high predictive power (92%). In contrast with prior studies,
Troupis et al. [39] assessed the sensitivity of 320-detector CT
for the detection of myocardial density changes based on rest
CCTA by comparing patients with severe coronary artery
stenoses (>75%) and patients with no stenosis. Comparison
of ischemicmyocardial segments with nonischemic segments
demonstrated no significant difference inmyocardial density,
confirming that myocardial ischemia cannot be reliably
detected on rest CCTA. Rest myocardial CTPmay have a role
in the assessment formyocardial infarction [40, 41]. However,
performance of only rest myocardial CTPmay be insufficient
to reliably rule out reversible ischemia [42].
Stress CTP is performed under pharmacological admin-
istration of stress agents, such as adenosine, dipyridamole,
or regadenoson, similar to nuclear medicine MPI [43]. In
the ischemic cascade, stress perfusion abnormalities aremore
sensitive than wall motion abnormalities [44]. Myocardial
CTP protocols typically include a stress and a rest phase
acquisition similar to a nuclear myocardial perfusion imag-
ing examination. When the time interval between the 2
scans is short, the myocardium in the second study may
be contaminated by previous injection of contrast material
which may decrease the sensitivity for detection of ischemic
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myocardium. Delay time of 10–20 minutes should be used
between the two CT scans to allow wash out of contrast from
themyocardium.During rest phase acquisition, prospectively
ECG-gated imaging can be performed with tube current and
voltage tailoring to bodymass index to reduce radiation dose.
Stress phase imaging is performed with pharmacologically
induced stress. The most commonly used stress agent in
perfusion imaging is vasodilator agent adenosine. Adenosine
is continuously infused at a dose of 0.14mg/kg per minute
over 3–5 minutes. Stress scan acquisition was performed at
peak contrast enhancement with a second bolus injection
of contrast [37]. Hypoattenuation areas in the myocardium
on CTP represent ischemic myocardium [45]. Generally, if
hypoattenuation areas are visualized at stress imaging only,
this may indicate reversible myocardial ischemia; if hypoat-
tenuation is visible at rest, this is suggestive of myocardial
infarction [43].
Studies have been conducted to investigate the diagnostic
performance of stress CTP for the evaluation of CAD.
Blankstein et al. [46] studied the diagnostic accuracy of
adenosine-stress CTP for identification of hemodynamically
significant stenosis compared with nuclear MPI using inva-
sive angiography as the reference standard. The stress CTP
had 96% sensitivity, 73% specificity, and 98% NPV on per-
vessel basis for the detection of stenosis ≥70%. Adenosine
stress CTP has comparable diagnostic accuracy to SPECT
in detecting stress-induced myocardial perfusion defects.
The comparison of stress myocardial perfusion imaging with
invasive fractional flow reserve (FFR) has been performed
by Ko et al. [47]. In this study, forty-two patients with
significant stenosis on invasive angiography were included
with use of 320-detector row CT. The sensitivity, specificity,
positive predictive value (PPV), and NPV of CTP on per-
vessel territory were 76%, 84%, 82%, and 79%, respectively.
Combining a ≥50% stenosis on CCTA and perfusion defect
on CTP was 98% specific for ischemia, while the presence
of normal perfusion on CTP and <50% stenosis on CCTA
was 100% specific for exclusion of ischemia. Feuchtner et al.
[33] reported stress myocardial CTP using dual-source CT
(DSCT) high-pitch mode for detecting reversible ischemia
with the comparison of MRI. Stress CTP had sensitivity of
96%, specificity of 88%, PPV of 93%, andNPV of 94% on per-
vessel basis. The accuracy increased from 84% to 95% after
adding stress CTP to CCTA. The results suggest that stress
myocardial CTP imaging with 128-slice high-pitch DSCT
is feasible for accurate detection of reversible myocardial
ischemia.
CORE320 is a multicenter multinational diagnostic study
whichwas designed to evaluate the diagnostic performance of
320-MDCT for detecting coronary stenosis and myocardial
perfusion deficits in patients with suspected CAD compared
with conventional coronary angiography and SPECT MPI
[48]. In this study, 381 patients who underwent combined
CCTA-CTP and SPECT-MPI prior to conventional coronary
angiography were enrolled from sixteen centers [49]. With
the advantage of temporal uniformity achieved by the use of
wide detector 320-MDCT system, the diagnostic accuracy of
combined CCTA and CTP for detecting or excluding flow-
limiting CAD was 0.87 on a patient-basis (defined by area
under the receiver operator characteristics curve, ROC). The
sensitivity, specificity, PPV, and NPV of integrated CCTA
stenosis and CTP perfusion deficit were 80%, 74%, 65%, and
86%, respectively. The accuracy of CCTA was significantly
improved by adding CTP at both the patient and vessel
levels. The study indicates that the combination of CCTA
andCTP correctly identifies patientswith flow-limitingCAD.
More recently, one study showed that combining CCTA and
CTP improves the diagnostic performance of coronary in-
stent restenosis and CAD in patients with stents compared
with CCTA alone [50]. The study is meaningful for clinical
decision making in these symptomatic patients.
The use of adenosine during stress CTP may increase the
heart rate. CTP is prone to motion artifacts particularly in
patients with high heart rate, which may compromise the
evaluation of myocardial perfusion. Combined CCTA/CTP
has been proven to have better diagnostic performance
than CCTA alone. Clinical outcome studies are still needed
to determine the effectiveness of stress CTP in evaluating
patients with known or suspected CAD compared with other
modalities.
4. Dual-Energy Myocardial CT Perfusion
Recently, CTP has been performed by using the dual-
energy mode. Dual-energy CT (DECT) is based on the
principle that body tissues and iodinated contrast have
specific spectral characteristics at different energy of X-
rays [51, 52]. DECT acquisition can be classified into two
categories: source-oriented and detector-oriented. Currently,
two popular approaches for performing DECT are either
with dual-source system to produce X-rays with two different
tube voltages or with a single X-ray tube switching rapidly
between low and high kilovoltage during a single scan [53].
After acquisition of the high- and low-energy data, the iodine
content within the myocardium can be determined using
the dedicated cardiac DECT postprocessing algorithm based
on the unique X-ray absorption characteristics of iodine at
different kV settings. The color-coded iodine distribution
maps superimposed on gray-scale multiplanar reformats of
the myocardium in short- and long-axis views are then
generated, which can be used for the detection of myocardial
ischemia [54] (Figure 1). The DE-CTP protocol commonly
involves rest scan and stress testing. The rest acquisition
is also used for coronary angiography evaluation. Stress
testing under the administration of adenosine is subsequently
performed with second bolus of iodine contrast medium
[52]. The potential advantage of DECT is that myocardial
perfusion defects are more conspicuous on iodine color
maps compared with single-energy CT evaluation [52, 55].
Perfusion defects could be visualized by using rest-only DE-
CTP [42]. Wang et al. [56] studied 34 patients with abnormal
SPECT findings or known CAD using only rest DECT.
Compared with SPECT, DECT had 68% sensitivity and 93%
specificity for the detection of myocardial perfusion defect.
Combining CCTA and rest DECT, the diagnostic accuracy
was slightly improved from 86% to 88% when compared
with CCTA alone using invasive coronary angiography as
the reference standard. The study indicates that combination
4 BioMed Research International
Figure 1: Curved multiplanar reformation of CCTA (A) shows severe stenosis in the left anterior descending artery (LAD). Coronary
angiography (B) demonstrates the occlusion in the proximal LAD. DE-CTP images show hypoperfusion at the anterior, apical, septal, and
inferior walls in the two and four-chamber views (C and D). SPECT-MPI images reveal perfusion defects in the same regions (E and F).
of DE-CTP and DE-CCTA may improve diagnostic perfor-
mance compared to CCTA alone for significant stenosis. One
study compared stress and rest DECT for the detection of
myocardial perfusion defects, and the results indicate that
stress DECT has superior performance for the detection of
perfusion defects compared with rest DECT with CMR as
the reference standard [57]. Ko et al. [58] investigated the
incremental value of combined CCTA and DE-CTP for the
detection of significant coronary stenoses. The study was
performed by adenosine-induced stress DE-CTP and con-
ventional coronary angiography. The sensitivity, specificity,
PPV, and NPV of the CCTA alone on a per-vessel basis were
91.8%, 67.7%, 73.6%, and 87.5%, respectively, and these values
were 93.2%, 85.5%, 88.3%, and 91.4% for combining CCTA
with CTP, respectively. The area under the ROC increased
from 0.798 to 0.893 (𝑃 = 0.004). The results indicate that
combined CCTA and CTP may provide incremental diag-
nostic value compared with CCTA alone for the detection of
significant coronary stenoses in patients withCAD, especially
in patients with heavily calcified plaques or implanted stents.
To evaluate the feasibility and diagnostic accuracy of stress
DECT for detecting hemodynamically significant stenosis
causing reversible myocardial perfusion defect, the same
group studied 41 patients with known CAD compared with
stress MR perfusion and conventional coronary angiography.
Stress DECT had sensitivity, specificity, and accuracy of 89%,
78%, and 82%, respectively, for detecting segments with
reversible perfusion defects compared with MR perfusion.
For the detection of vascular territories with reversible
perfusion defect that had hemodynamically relevant CAD,
stress DECT had 89% sensitivity, 76% specificity, and 83%
accuracy comparedwith conventional coronary angiography.
The results demonstrate that stress DECT has the potential
to identify stress-induced myocardial perfusion defect in
patients with CAD. It should be noted that DE-CTP is more
susceptible tomotion artifacts during adenosine infusion and
beam-hardening artifacts which mimics perfusion defects
and led to false positives [59]. Recent studies also suggest
that rapid kV-switching projection-based DECT could be an
effective technique for eliminating the beam-hardening effect
due to the ability to reconstruct monochromatic CT images;
thus, it may permit improved quantitative myocardial CTP
[60, 61]. Although the limited study results demonstrate that
DECT-based evaluation of myocardial perfusion defects has
the potential for the assessment of hemodynamically signif-
icant coronary stenosis in patients with CAD, more future
studies will be required before DECT can be incorporated
into routine clinical application.
5. Dynamic Myocardial CT Perfusion
Single-phase first-pass CTP is highly dependent on accurate
bolus timing and thus the peak attenuation may be missed
because of the acquisition of only one sample of the data.
A dynamic CT perfusion scan can be performed while the
scanning table is stationary or in shuttle mode [62, 63].
During the shuttle mode imaging, data are acquired over
a 30-second interval with the table moving forward and
backward between both positions to cover a scan range of
73mm. Dynamic CTP has the advantage of capturing an
entire dynamic series of contrast-enhanced myocardium at
stress and at rest. From the acquired multiphase CT images,
time-density curve (TDC) of the myocardium and its supply
arteries are measured. The myocardial blood flow (MBF)
and myocardial blood volume (MBV) can be derived from
TDC using various mathematical models, leading to quanti-
tative assessment of regional perfusion [45, 64]. Quantitative
assessment of MBF offers clinical values over qualitative
assessment ofMBF, including the potential to detect balanced
ischemia and absolute measurement of perfusion, which is
better to grade the severity of ischemia [65].
The feasibility of dynamic CTP for the detection of hemo-
dynamically significant coronary stenosis was investigated
by Bamberg et al. [66] with invasive fractional flow reserve
(FFR) as a reference standard. In the study, an MBF cut point
of 75mL/100mL/min was determined for the differentiation
between hemodynamically significant and nonsignificant
coronary stenoses on the basis of maximization of the area
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under the curve. With use of estimated MBF to reclassify the
lesions, the PPVwas significantly increased from 49% to 78%
compared with CCTA. The results suggest that dynamic CT-
based stress MPI provide incremental diagnostic value for
the detection of hemodynamically significant coronary artery
stenosis. A recent study of stress dynamic CTP for the evalu-
ation of myocardial ischemia and infarction was performed
with CMR as the reference standard [67]. In this study, a
threshold of 88mL/100mL/min for MBF was determined
to indicate a perfusion defect. The diagnostic accuracy of
CTP for the detection of any perfusion defect was good with
77.8% sensitivity, 75.41% specificity, 91.3% NPV, and 50.6%
PPV. Higher diagnostic accuracy was defined for transmural
perfusion defects with 87.8% sensitivity and infarcted seg-
ments with 85.3% sensitivity. MBV was significantly lower
in infarcted segments compared with ischemic segments.
The study indicates that dynamic stress CTP provides good
diagnostic accuracy for the detection of myocardial perfu-
sion defects and has the potential to differentiate ischemic
from infracted myocardium. Wang et al. [63] studied the
adenosine-stress dynamic CTP compared with conventional
coronary angiography and SPECT. In this study, moderate
correlation was observed between adenosine-stress CTP and
SPECT-MPI (𝑟 = 0.639). The combination of CTP with
CCTA improves the diagnostic accuracy for identifying flow-
limiting stenosis compared with CCTA alone.
The comparison of dynamic with single-phase CT acqui-
sition for MPI has been recently studied. One study demon-
strated similar performance of single-phase peak enhance-
ment to the perfusion parameter MBF in the detection
of ischemic myocardium [68]. Another study showed that
dynamic acquisition techniques allow the identification of
more subtle perfusion changes at moderate stenosis (50%),
whereas both techniques permit the identification of high-
grade stenosis (75%). The results also suggest that dynamic
myocardial CTP may be more sensitive in the detection of
subtle differences of myocardial perfusion compared with
single-phase perfusion imaging [69]. Currently, wide detec-
tor CT system allows for covering the entire left ventricular
myocardium without table movement and is more suitable
for dynamic CTP imaging [62]. Manual postprocessing of
dynamic myocardial perfusion CT data has been time-
consuming and laborious. Accordingly, the automated soft-
ware for perfusion analyses is desirable to facilitate rapid
interpretation and enhance reproducibility. Ebersberger et
al. [70] reported the use of 3D semiquantitative software
for the analysis of myocardial perfusion CT data with
SPECT as the reference standard. The results indicate that
the 3D semiquantitative software substantially decreases
postprocessing and interpretation times while maintaining
the diagnostic accuracy. Since dynamic myocardial CTP
involves multiphase scans, dose issue is the major concern.
Therefore, care must be taken to minimize the radiation
dose while maintaining the clinically relevant information.
The studies have shown promising results, and the use of
dynamic myocardial CTP may allow for accurate assessment
of the hemodynamically significant coronary stenosis. How-
ever, further research will be required to verify the clinical
effectiveness of this approach.
6. Delayed Enhancement CT
Delayed enhancement CT was found to be feasible for the
assessment myocardial infarction and viability. Hyperen-
hanced myocardial areas on delayed CT images may repre-
sent scar tissue caused bymyocardial infarction.However, the
contrast-to-noise ratio between the infarcted region and the
normal myocardium is limited compared with CMR delayed
enhancement imaging [52, 71]. One study suggested that
delayed enhancement CT does not add incremental diagnos-
tic value to CTP. Thus, delayed enhancement acquisition can
be omitted to reduce radiation dose [42]. Current data are
insufficient to support the use of delayed enhancement CT
for the assessment of myocardial viability in patients with
suspected CAD.
7. Limitations and Prospect of CT Perfusion
Themain limitations of CTP currently are artifacts, radiation
exposure, and contrast load. Artifacts can alter myocardial
attenuation and interfere with myocardial perfusion analysis,
which may result in misinterpretation of myocardial blood
flow and perfusion defects [72]. It has been shown that in
a group of asymptomatic patients with no history of CAD,
who undergo CT perfusion angiography, artifacts in the
posterobasal wall were identified in more than two-thirds of
patients [73].These low-attenuation pseudoperfusion defects
can largely be ascribed to beam-hardening artifacts most
likely from the adjacent bone structures. The high iodine
concentration in the descending aorta and left ventricular
chamber, however, can also result in beam-hardening arti-
facts that can mimic the appearance of myocardial perfusion
defects and should be taken into account in the judgment
of CT perfusion images. Therefore, beam-hardening artifact
correction for coronary CT imaging is essential for accu-
rate assessment of myocardial perfusion imaging. Recent
study shows that image-based beam-hardening correction
algorithm is feasible for the correction of beam-hardening
artifacts that mimic perfusion defects. The beam-hardening
correction used in the study was an image-based correc-
tion algorithm that enables individual estimation of the
beam hardening from high-enhancing material and water-
enhancing material for accurate calculation of the amount
of beam hardening and to reconstruct a corrected image [74,
75].The study also demonstrates that virtual monochromatic
images generated using fast-switching dual-kVp technology
are feasible for the correction of beam-hardening artifacts
in myocardial CT imaging [71]. However, beam-hardening
artifacts cannot be completely eliminated using the current
beam-hardening correction algorithms [74]. In the near
future, more rigorous correction algorithms for CTP imaging
may improve accurate assessment of myocardial perfusion.
The increasing radiation exposure to the total population
due to CT scans has raised serious concerns [76]. The main
concern of exposure to ionizing radiation is the potential risk
of cancer [77]. Another important limitation in myocardial
CTP is the relatively high radiation dose. Stress testing
requires repeated scanning that is associated with additional
radiation exposure. In comparison with static CTP, dynamic
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myocardial CTP techniques involve much higher radiation
exposure to the patients, because of the use of multiple
phases. Notably, radiation doses are steadily decreasing as
more dose-reduction strategies such as prospective ECG-
gating, low tube voltage, and automatic tube current mod-
ulation are performed [78–80]. In Blankstein’s study [46],
the average radiation exposure for the complete CT proto-
col including rest perfusion, stress perfusion, and delayed
enhancement scan was 12.7 ± 4.0mSv which is similar to
SPECT (12.7 ± 0.4mSv). In a recent study, by Feuchtner et al.
[33], lower radiation doses can be achieved by using the latest
dual-source CT with high-pitch mode, with a mean effective
dose of 0.93 ± 0.18mSv (range: 0.75–1.48mSv) for stress
and 1.59 ± 1.3mSv (range: 0.53–5.8mSv) for rest imaging,
respectively.The use of iterative reconstruction algorithm can
improve signal-to-noise ratio (SNR) and contrast-to-noise
ratio (CNR) and may facilitate radiation dose savings in CTP
without influencing diagnostic quality [81].
Besides the radiation, concerns about iodine con-
trast associated with CTP remain to be addressed, espe-
cially in patients with abnormal renal function. Combined
CCTA/CTP requires doubling the iodinated contrast dose
compared with CCTA alone. The repeated scanning in stress
testing requires additional iodine contrast. Recent studies
have demonstrated 74% reduction in radiation and 28%
reduction in contrast dose without significantly compromis-
ing the ability to detect stress-induced myocardial ischemia
by using lower tube voltage [78]. Therefore, optimizing the
scan protocol to reduce radiation exposure and contrast
dose is important formyocardial perfusion imaging. Another
limitation during performing CTP is the use of beta-blockers
for heart rate control which may mask ischemia [82].
Myocardial CTP has the potential to noninvasively assess
both coronary artery stenosis and its functional significance
at a single examination. Current evidence indicates that
the combination of CCTA with CTP imaging may improve
diagnostic accuracy compared with CCTA alone for the eval-
uation of suspected CAD. Future advances of CT technology
with improved spatial and temporal resolution and detector
widths, as well as beam-hardening correction algorithms,
will enhance the diagnostic accuracy of CTP. CTP would be
performed with very low radiation dose and free of beam-
hardening artifacts. More studies will be required to further
define the diagnostic value of combined CCTA and CTP.
Longer term follow-up studies are needed to validate the
prognostic value of CTP, as well as the patient outcomes
of CTP-guided clinical decision making. Although CTP has
shown the potential to evaluate the hemodynamic signifi-
cance of stenotic lesions, there is still no strong evidence to
support the routine clinical use of this novel technique.
8. Noninvasive FFRCT
FFR is widely accepted as the gold standard invasive phys-
iologic test for the assessment of lesion-specific ischemia
[83, 84]. FFR has been shown to be valuable for the identi-
fication of lesions which can benefit from revascularization
or can be safely deferred. FFR-guided percutaneous coronary
intervention (PCI) results in a significant reduction in major
adverse events as compared to PCI-guided by angiography
alone [83]. FFR is defined as the ratio of the mean coronary
pressure distal to a coronary stenosis to the mean aortic
pressure duringmaximal coronary blood flow. It can be easily
measured during coronary angiography with a coronary
pressure guidewire. A FFR value of 0.80 or less identifies
hemodynamic significance of coronary stenosis [85]. In
comparison toMPI that identifies territory-specific ischemia,
the advantage of FFR is the assessment of ischemia at the
lesion level. However, FFR is an invasive procedure and is not
suitable for routine patient evaluation.
Recently,The FFR can be computed from standard CCTA
scans (FFRCT) with the advances in computational fluid
dynamics and image-based modeling. FFRCT is a novel non-
invasive technique that can be used to determine the phys-
iologic significance of coronary stenosis without any modi-
fication of CCTA protocols, additional image acquisition, or
administration of medications [86]. FFRCT is calculated by
computational fluid dynamic (CFD) modeling after semiau-
tomated segmentation of coronary tree and left ventricular
mass.Three-dimensional bloodflowandpressure of the coro-
nary arteries can be simulated, with bloodmodeled as a New-
tonian fluidwith incompressibleNavier-Stokes equations and
solved subject to appropriate initial and boundary conditions
with a finite element method on parallel supercomputer
[87, 88]. The FFRCT is modeled for conditions of adenosine-
induced hyperemia without adenosine infusion.This process
is computationally complex and time-consuming and may
require several hours. Similar to invasive FFR, FFRCT was
obtained by dividing themean pressure distal to the coronary
stenosis by the mean aortic pressure. An FFRCT < 0.80
was considered diagnostic of lesion-specific ischemia [86].
Up to now, limited FFRCT studies have been performed.
In the DISCOVER-FLOW (Diagnosis of Ischemia-Causing
Stenoses Obtained Via Noninvasive Fractional Flow Reserve)
trial [86], FFRCT was performed on 159 vessels in 103
patients with suspected or known CAD undergoing CCTA
and invasive coronary angiography. The diagnostic perfor-
mance of FFRCT and CCTA stenosis for the detection of
ischemia-causing lesions was assessed with invasive FFR
as the reference standard. The results demonstrate that the
per-vessel accuracy, sensitivity, specificity, PPV, and NPV of
FFRCT were 84.3%, 87.9%, 82.2%, 73.9%, 92.2%, respectively,
and were 58.5%, 91.4%, 39.6%, 46.5%, 88.9%, respectively, for
CCTA stenosis. The area under the ROC was 0.90 for FFRCT
and 0.75 for CCTA (𝑃 < 0.001). The specificity and PPV
were remarkably improved by FFRCT compared with CCTA
stenosis. The DeFACTO (Determination of Fractional Flow
Reserve by Anatomic Computed Tomographic Angiography)
trial [89], a multicenter international study which consisted
of 252 patients, was designed to evaluate the performance
of noninvasive FFRCT for the diagnosis of ischemia with
invasive FFR as a reference standard. On a per-patient basis,
diagnostic accuracy, sensitivity, specificity, PPV, and NPV
of FFRCT plus CCTA were 73%, 90%, 54%, 67%, and 84%,
respectively.When comparing FFRCT withCCTA stenosis for
diagnosing obstructive CAD, FFRCT demonstrated improved
discrimination with area under the ROC 0.81 for FFRCT and
0.68 for CCTA (𝑃 < 0.001). The study results demonstrated
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improved diagnostic accuracy of FFRCT plus CCTA versus
CCTA alone for the diagnosis of ischemia, although the study
did not achieve its prespecified primary outcome goal of
diagnostic accuracy of greater than 70% of the lower bound
of the sided 95% confidence interval (95% CI, 67%–78%).
The study suggests the potential of FFRCT as a promising
noninvasive method for the identification of individuals
with ischemia. More recently, the multicenter study NXT
(Analysis of Coronary Blood Flow Using CT Angiography:
Next Steps) trial [90] included 251 patients scheduled to
undergo clinically indicated invasive coronary angiography
for suspected CAD.The diagnostic performance of FFRCT for
the diagnosis of ischemia was determined with invasive FFR
as the reference standard. As compared to previous studies
[86, 89], the improved FFRCT technology was used with an
emphasis on CCTA image quality. The area under the ROC
curve for FFRCT was 0.90 versus 0.81 for CCTA (𝑃 = 0.0008).
On per-patient basis, sensitivity and specificity to identify
ischemia were 86% and 79% for FFRCT versus 94% and
34% for CCTA, respectively. When compared to CCTA, the
improved diagnostic performance of FFRCT is in particular
with regard to specificity.The study demonstrates that FFRCT
has relatively high diagnostic accuracy compared to invasive
FFR for identifying hemodynamically significant CAD.
FFRCT technology enables the “virtual stenting” model-
ing and may be served to predict hemodynamic effect of
coronary stenting on ischemia-causing stenoses [91]. Kim
et al. [92] studied the application of FFRCT in 44 patients
(48 lesions) to predict FFR value changes after stenting with
invasive FFR as the reference standard. Before intervention,
invasive FFR was 0.70 ± 0.14 and increased to 0.90 ± 0.05
after stenting. FFRCT was 0.70 ± 0.15 before intervention and
increased to 0.88 ± 0.05 after virtual coronary stenting.There
was a good correlation between FFR and FFRCT before (𝑅 =
0.60; 𝑃 < 0.001) and after stenting (𝑅 = 0.55; 𝑃 < 0.001).
This study demonstrates that virtual stenting by FFRCT is
feasible and may be helpful for revascularization planning
before invasive procedures.
9. Limitations and Prospect of FFRCT
There are several limitations for physiologic assessment of
coronary stenosis by FFRCT. First, FFRCT is calculated by
computational simulation of adenosine mediated hyperemia
rather than by actual administration of adenosine. Second,
the value of FFRCT is influenced not only by stenosis severity
but also by the presence of viable or scarredmyocardium [93].
Third, the calculated FFRCT valuesmay be lower than those of
measured FFR in patients with microvascular disease, for the
modeling of adenosine-induced hyperemiamay overestimate
the degree of vasodilation [88]. Fourth, because FFRCT
requires accurate anatomic models, numerous artifacts on
CCTA may affect FFRCT calculation, including the presence
of heavy calcification, motion artifacts, lower SNR, and
misregistration. Therefore, CCTA data with good image
quality is essential for the accuracy of FFRCT interpretation.
The results of the limited studies indicate that FFRCT
is feasible for noninvasive determination of lesion-specific
ischemia. Although the accuracy of FFRCT was reported
as modest in several multicenter trials, this novel tech-
nique shows promise not only for diagnosing lesion-specific
ischemia but also for predicting revascularization benefit.
The present studies support the potential of CCTA with
FFRCT as a gatekeeper to invasive coronary angiography and
revascularization. Further improvements in the technology
or new algorithms for a reliable estimation of FFR will be
a prerequisite for wide acceptance of FFRCT, and further
studies are needed to determine its clinical utility compared
with other noninvasive testing. Combination of CCTA and
FFRCT might permit evaluation of CAD in a “one-stop-shop”
approach in the future.
10. Transluminal Attenuation Gradient (TAG)
Assessment of the change in intraluminal contrast attenu-
ation across a coronary stenosis on CCTA may allow pre-
diction of functional significance of coronary stenosis [94].
A methodology called “coronary opacification” (CO) differ-
ence, defined as the contrast attenuation difference across
a stenosis, has been proposed for functional prediction of
stenosis. In the study, by Chow et al. [95], attenuation values
of coronary lumen were measured before and after stenoses
and normalized to the descending aorta on the same axial
slice, because the image acquisition is not temporally uniform
using 64-slice CT. Corrected coronary opacification (CCO)
differences were compared with the severity of coronary
stenosis and thrombolysis in myocardial infarction (TIMI)
flow at invasive coronary angiography. The results indicate
that changes inCCOacross coronary stenoses seem to predict
abnormal resting coronary blood flow.
However, the measurement of gradients across coronary
stenoses is inherently more robust than evaluation of opaci-
fication difference. Transluminal attenuation gradient (TAG)
is defined as the linear regression coefficient between luminal
attenuation (Hu) and axial distance along the vessel from
the coronary ostium. TAG is reflected by the kinetics of
the iodinated contrast media within the coronary arteries.
Study confirmed that opacification gradients exist in patients
with normal coronary arteries. The TAG along the course
of a coronary artery can be reproducibly evaluated with
CCTA [96]. The hypothesis of TAG as a functional test is
that contrast attenuation should fall off more rapidly across
a lesion with functionally significant stenosis [97]. Recent
studies suggest that TAGmay provide useful information for
the assessment of functional significance of coronary stenosis
with the comparison of invasive FFR. TAG significantly
improves both sensitivity and specificity over CCTA stenosis
degree alone [94].
It has been reported that TAG has the potential to
improve the classification of stenosis severity on 64-slice
CCTA compared with coronary angiography as a reference
standard, especially in calcified lesions, which is particularly
useful because CCTA is limited in accuracy when lesions are
calcified [98]. The limitation of TAG analysis, using 64-slice
CCTA, pointed out by the authors, is that attenuation along a
vessel does not reflect contrast density at a single time point,
potentially limiting the diagnostic performance of the TAG
method. The use of 320-detector row CT with whole-heart
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volume to be imaged in a single gantry rotation enables
noninvasive quantitative assessment of coronary contrast
changes with temporal uniformity, which may be ideal for
TAG functional assessment of a coronary arterial stenosis
[94, 96]. Comparing labor-intensivemanual TAG calculation
methods, latest automated gradient software package can
reduce computation time with high accuracy and repro-
ducibility [99].
Combined TAG and CCTA assessment may have incre-
mental value over CCTA alone for detecting functionally
significant coronary stenoses, especially in severely calcified
lesions. TAG depends on the luminal attenuation values,
and the accuracy of quantification may be influenced by
various artifacts on CCTA. So, maintaining image quality of
CCTA is important for TAG analysis. TAG assessment has
particular attraction, as it does not require additional scan
or complex computation compared with CT perfusion or
FFRCT. However, given the limited evidence so far, larger
studies with current acquisition and reconstruction protocols
as well as new analysis software are required to validate the
diagnostic and prognostic value of this approach.
11. Summary
CCTAhas become an important noninvasive imagingmodal-
ity in the diagnosis of CAD. CCTA enables accurate eval-
uation of coronary artery stenosis. However, CCTA pro-
vides limited information on the physiological significance
of stenotic lesions. There is a great interest in evaluating
both coronary anatomy and its hemodynamic significance
during a single examination. Combination of anatomic and
physiologic information would be beneficial for clinical deci-
sion making, particularly in lesions with moderate stenoses.
Recently, novel CT techniques which can provide both
anatomical and functional assessments of CAD were devel-
oped, including myocardial CTP and noninvasive FFRCT,
which simulate FFR from CT data using CFD method and
TAG derived from the gradient in contrast opacification
along a coronary artery. The current studies have demon-
strated that thesemethods are feasible for noninvasive assess-
ment of CAD and have the potential to provide incremental
value in detecting functionally significant coronary stenosis
over CCTA alone. Although the currently available data
are promising, these approaches are still in its early stage,
and their diagnostic values still need further validation.
Further research is required to identify the prognostic value
and clinical outcomes of decision making based on these
techniques.
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